Cargando…
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
Genomic analysis has recently identified multiple ESR1 gene translocations in estrogen receptor alpha–positive (ERα(+)) metastatic breast cancer (MBC) that encode chimeric proteins whereby the ESR1 ligand binding domain (LBD) is replaced by C-terminal sequences from many different gene partners. Her...
Autores principales: | Gou, Xuxu, Anurag, Meenakshi, Lei, Jonathan T., Kim, Beom-Jun, Singh, Purba, Seker, Sinem, Fandino, Diana, Han, Airi, Rehman, Saif, Hu, Jianhong, Korchina, Viktoriya, Doddapaneni, Harshavardhan, Dobrolecki, Lacey E., Mitsiades, Nicholas, Lewis, Michael T., Welm, Alana L., Li, Shunqiang, Lee, Adrian V., Robinson, Dan R., Foulds, Charles E., Ellis, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234971/ https://www.ncbi.nlm.nih.gov/pubmed/34711608 http://dx.doi.org/10.1158/0008-5472.CAN-21-1256 |
Ejemplares similares
-
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer
por: Gou, Xuxu, et al.
Publicado: (2023) -
ESR1 alterations and metastasis in estrogen receptor positive breast cancer
por: Lei, Jonathan T., et al.
Publicado: (2019) -
ESR1 fusions drive endocrine therapy resistance and metastasis in breast cancer
por: Lei, Jonathan T., et al.
Publicado: (2018) -
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer
por: Dustin, Derek, et al.
Publicado: (2020) -
Sequencing of a central nervous system tumor demonstrates cancer transmission in an organ transplant
por: Gingras, Marie-Claude, et al.
Publicado: (2021)